Literature DB >> 23404156

Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia.

B Maneesha Silva1, Anna E Hosman, Hannah L Devlin, Claire L Shovlin.   

Abstract

OBJECTIVES/HYPOTHESIS: To identify factors influencing the severity of epistaxis in hereditary hemorrhagic telangiectasia (HHT). STUDY
DESIGN: Participants with and without HHT were recruited from a specialist service and online following advertisement by the HHT Foundation International. Both groups were asked to complete a nonbiased questionnaire.
METHODS: The reported effects of specific treatments or lifestyle factors on epistaxis were assigned positive values if beneficial, negative values if detrimental, or zero if "no difference" and were summed to enable statistical analysis.
RESULTS: Epistaxis affected 649 of 666 (97%) participants with HHT and was significantly more frequent than in control participants. Specialist invasive treatments were reported as beneficial, laser therapy more frequently than cauterization. Medical treatments commonly used for HHT epistaxis (female hormones, antiestrogens, tranexamic acid, aminocaproic acid, nasal creams, and bevacizumab) also had significantly positive (beneficial) scores. Lifestyle and dietary factors were generally detrimental, but room humidification, nasal lubrication, and saline treatments were all reported as beneficial (95% confidence intervals greater than zero). Multiple food items were volunteered as being detrimental to epistaxis. The most frequently reported items were alcohol (n = 45; 6.8% of participants) and spices (n = 26, 3.9% of participants). Remaining foods reported to exacerbate epistaxis were also found to be high in salicylates (including red wine, spices, chocolate, coffee, and certain fruits), natural antiplatelet activity (garlic, ginger, ginseng, ginkgo biloba, and vitamin E15), or omega-3 acids (oily fish, salmon).
CONCLUSIONS: This study supports existing treatments and suggests lifestyle and dietary maneuvers that may also improve nosebleeds in HHT. LEVEL OF EVIDENCE: 2c.
Copyright © 2013 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23404156     DOI: 10.1002/lary.23893

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  17 in total

1.  Dietary supplement use and nosebleeds in hereditary haemorrhagic telangiectasia - an observational study.

Authors:  Basel Chamali; Helen Finnamore; Richard Manning; Michael A Laffan; Mary Hickson; Kevin Whelan; Claire L Shovlin
Journal:  Intractable Rare Dis Res       Date:  2016-05

2.  Whole genome sequences discriminate hereditary hemorrhagic telangiectasia phenotypes by non-HHT deleterious DNA variation.

Authors:  Katie E Joyce; Ebun Onabanjo; Sheila Brownlow; Fadumo Nur; Kike Olupona; Kehinde Fakayode; Manveer Sroya; Geraldine A Thomas; Teena Ferguson; Julian Redhead; Carolyn M Millar; Nichola Cooper; D Mark Layton; Freya Boardman-Pretty; Mark J Caulfield; Claire L Shovlin
Journal:  Blood Adv       Date:  2022-07-12

3.  Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency.

Authors:  Helen Finnamore; James Le Couteur; Mary Hickson; Mark Busbridge; Kevin Whelan; Claire L Shovlin
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

4.  Arterial oxygen content is precisely maintained by graded erythrocytotic responses in settings of high/normal serum iron levels, and predicts exercise capacity: an observational study of hypoxaemic patients with pulmonary arteriovenous malformations.

Authors:  Vatshalan Santhirapala; Louisa C Williams; Hannah C Tighe; James E Jackson; Claire L Shovlin
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

5.  Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls.

Authors:  Anna E Hosman; Hannah L Devlin; B Maneesha Silva; Claire L Shovlin
Journal:  Orphanet J Rare Dis       Date:  2013-12-20       Impact factor: 4.123

6.  A postal survey of hereditary hemorrhagic telangectasia in the northeast of England.

Authors:  Yujay Ramakrishnan; Isma Z Iqbal; Mark Puvanendran; Mohamed Reda ElBadawey; Sean Carrie
Journal:  Allergy Rhinol (Providence)       Date:  2015-01

Review 7.  Optimal management of hereditary hemorrhagic telangiectasia.

Authors:  Neetika Garg; Monica Khunger; Arjun Gupta; Nilay Kumar
Journal:  J Blood Med       Date:  2014-10-15

8.  Embolisation of PAVMs reported to improve nosebleeds by a subgroup of patients with hereditary haemorrhagic telangiectasia.

Authors:  Claire L Shovlin; Trishan Patel; James E Jackson
Journal:  ERJ Open Res       Date:  2016-04-29

9.  Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia.

Authors:  Claire L Shovlin
Journal:  Front Genet       Date:  2015-04-09       Impact factor: 4.599

10.  Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: associations with iron deficiency and platelets.

Authors:  Claire L Shovlin; Basel Chamali; Vatshalan Santhirapala; John A Livesey; Gillian Angus; Richard Manning; Michael A Laffan; John Meek; Hannah C Tighe; James E Jackson
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.